Posted by Michael Wonder on 28 Aug 2019
Promoting paediatric drug research and labelling — outcomes of legislation
28 August 2019 - Congress has modified regulations of the FDA to promote research assessing the efficacy and safety of drugs in children.
The authors examine how this legislation has affected pAediatric drug development and research over the past 20 years and discuss options for additional reforms to accelerate progress in this area.
